Text Size

Adjunctive use of tafluprost with timolol provides additive effects for reduction of intraocular pressure in patients with glaucoma

Egorov E., Ropo A., Erichev V., Astakhov Y., Alekseev V., Takhchidi K., Zhaboedov G., Pasechnikova N., Kaljurand K., Palumaa K., Lagnovska G., Eugeny E.E.A., Staritskaya T.V., Evgen'evna E.T., Borisovna R.T., Sheremetyeva S.S., Oganezova J.G., Petrovich E.V., Vagizona Y.L., Sergueevich A.Y., Alekseevna D.G., Borisovna L.A., Kasimovna A.L., Victorovich P.A., Levko M., Martynova E., Kolotov A., Mironova E.M., Proshina O.I., Kozlova E.E., Sochinskaya V.K., Grishina T.S., Zhaboedov G.D., Petrenko O.V., Tymoshenkova O.V., Vitovska O.P., Kurilina O.I., Parkhomenko O.G., Pasechnokova N.V., Korol A.R., Klyuev G.O., Romodanova K.S., Nevska A., Padanevych E., Kaljurand K., Pastak M., Seljagina N., Palumaa K., Somma K., Laganovska G., Baumane K.


  • 2009
  • European Journal of Ophthalmology
View publication
  • Therapeutic Area

    Glaucoma

  • Categories

    Clinical development

  • Affiliations

    Russian State Medical University, 1 Ostrovitjanova Street, 117997 Moscow, Russian Federation; Santen Oy, Clinical Research, Helsinki, Finland

Related Publications

Metabolomic Profiling of Open-Angle Glaucoma Etiologic Endotypes: Tohoku Multi-Omics Glaucoma Study

Hanyuda A.; Raita Y.; Ninomiya T.; Hashimoto K.; Takada N.; Sato K.; Inoue J.; Koshiba S.; Tamiya G.; Narita A.; Akiyama M.; Omodaka K.; Tsuda S.; Yokoyama Y.; Himori N.; Yamamoto Y.; Taniguchi T.; Negishi K.; Nakazawa T.


Ocular Tissue Distribution of Omidenepag Isopropyl in Rabbits and Cynomolgus Monkeys

Yamamura K.; Mano H.; Fuwa M.; Ryoiwamura; Odani-Kawabata N.


Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial

Wang T.H.; Aung T.; Lu D.-W.; George R.; Senthil S.; Lu F.; Odani-Kawabata N.; Park K.H.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022